Workflow
宏力达: 宏力达关于向公司2025年限制性股票激励计划激励对象授予预留限制性股票的公告

Core Viewpoint - The company has approved the grant of reserved restricted stock under its 2025 Restricted Stock Incentive Plan, with specific conditions met for the grant [1][5][12]. Summary by Sections Restricted Stock Grant Details - The reserved grant date is set for July 28, 2025, with a total of 79,700 shares to be granted at a price of 14.76 yuan per share, representing 0.06% of the company's total share capital of 14 million shares [5][12]. - The grant is directed towards three middle management and technical personnel [10][11]. Decision-Making Process - The decision to grant the restricted stock has undergone necessary approvals from the board and the supervisory committee, confirming compliance with relevant regulations [3][4][14]. - The company has publicly disclosed the names and positions of the incentive recipients, with no objections raised during the public notice period [2][6]. Compliance with Grant Conditions - The board has verified that both the company and the incentive recipients meet all conditions for the grant, as outlined in the incentive plan [7][8]. - The conditions include no adverse audit opinions or legal restrictions affecting the company or the recipients [6][7]. Vesting Schedule - The vesting of the granted restricted stock will occur in two phases: 50% after 12 months and the remaining 50% after 24 months from the grant date [9][10]. - The stock cannot be transferred or used as collateral before vesting [10]. Financial Impact - The company will measure the fair value of the restricted stock using the Black-Scholes model, with the associated costs recognized in the financial statements over the vesting period [12][13]. - The estimated total expense for the reserved stock grant will be amortized over the years 2025 to 2027 [13]. Legal and Financial Advisory Opinions - Legal and financial advisors have confirmed that the grant complies with all applicable laws and regulations, ensuring the legitimacy of the incentive plan [14][15].